Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study

about

Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study

Item

http://www.wikidata.org/entity/Q58778034

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Clinical signs and symptoms in ...... inal, multicenter cohort study

@en

Clinical signs and symptoms in ...... inal, multicenter cohort study

@nl

type

Item

label

Clinical signs and symptoms in ...... inal, multicenter cohort study

@en

Clinical signs and symptoms in ...... inal, multicenter cohort study

@nl

prefLabel

Clinical signs and symptoms in ...... inal, multicenter cohort study

@en

Clinical signs and symptoms in ...... inal, multicenter cohort study

@nl

P1476

Clinical signs and symptoms in ...... inal, multicenter cohort study

@en

P2093

Claire T. Deakin

http://www.w3.org/2001/XMLSchema#string

E. H. Pieter van Dijkhuizen

http://www.w3.org/2001/XMLSchema#string

Lucy R. Wedderburn

http://www.w3.org/2001/XMLSchema#string

Maria De Iorio

http://www.w3.org/2001/XMLSchema#string

P2860

Update in juvenile myositis

Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies

Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-

Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.

Polymyositis and dermatomyositis (second of two parts).

Polymyositis and dermatomyositis (first of two parts).

Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.

The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.

Analysis of Published Criteria for Clinically Inactive Disease in a Large Juvenile Dermatomyositis Cohort Shows That Skin Disease Is Underestimated

P2888

s13075-018-1687-8

P31

scholarly article

P356

10.1186/S13075-018-1687-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106151521

http://www.w3.org/2001/XMLSchema#string

P698

30111380

http://www.w3.org/2001/XMLSchema#string

P921

dermatomyositis

P932

6094880

http://www.w3.org/2001/XMLSchema#string